Long-Term Changes in Human Colonic Bifidobacterium Populations Induced by a 5-Day Oral Amoxicillin-Clavulanic Acid Treatment

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Mangin, Irène ^a,b   Lévêque, Christophe ^a,b   Magne, Fabien ^a   Suau, Antonia ^a,c   Pochart, Philippe ^a,b  

^a Laboratoire de Biologie   (France)

^b FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^c UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID;

ADULT; AGED; ARTICLE; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANGULATUM; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM CATENULATUM; BIFIDOBACTERIUM DENTIUM; BIFIDOBACTERIUM GALLICUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; COLON FLORA; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DRUG EXPOSURE; HUMAN; HUMAN EXPERIMENT; MICROBIAL DIVERSITY; MICROBIAL POPULATION DYNAMICS; NORMAL HUMAN; PROTEIN DENATURATION;

ADULT; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BIFIDOBACTERIUM; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA, BACTERIAL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FECES; GENES, RRNA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SPECIES SPECIFICITY; TIME FACTORS;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM;

EID: 84870283781     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050257     Document Type: Article

References (47)

1. Guarner F, Malagelada JR, (2003) Gut flora in health and disease. Lancet 361: 512-519.
2. Moore WE, Moore LH, (1995) Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 61: 3202-3207.
3. Dethlefsen L, McFall-Ngai M, Relman DA, (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449: 811-818.
4. Sullivan A, Edlund C, Nord CE, (2001) Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 1: 101-114.
5. Hurley BW, Nguyen CC, (2002) The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med 162: 2177-2184.
6. Bergogne-Berezin E, (2000) Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Agents 16: 521-526.
7. Finegold SM, Sutter VL, Mathisen GE (1983) Normal indigenous intestinal flora. In: Hentges DJ, editors. Human intestinal microflora in health and disease. New York: Academic Press. pp. 3-31.
8. Matsuki T, Watanabe K, Tanaka R, Fukuda M, Oyaizu H, (1999) Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 65: 4506-4512.
9. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, et al. (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469: 543-547.
10. Lee JH, Li X, O'Sullivan DJ, (2011) Transcription analysis of a lantibiotic gene cluster from Bifidobacterium longum DJO10A. Appl Environ Microbiol 77: 5879-5887.
11. Picard C, Fioramonti J, Francois A, Robinson T, Neant F, et al. (2005) Review article: bifidobacteria as probiotic agents- physiological effects and clinical benefits. Aliment Pharmacol Ther 22: 495-512.
12. Vasquez N, Suau A, Magne F, Pochart P, Pelissier MA, (2009) Differential effects of Bifidobacterium pseudolongum strain Patronus and metronidazole in the rat gut. Appl Environ Microbiol 75: 381-386.
13. Delgado S, Florez AB, Mayo B, (2005) Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract. Curr Microbiol 50: 202-207.
14. Lim KS, Huh CS, Baek YJ, (1993) Antimicrobial susceptibility of bifidobacteria. J Dairy Sci 76: 2168-2174.
15. Masco L, Van Hoorde K, De Brandt E, Swings J, Huys G, (2006) Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products. J Antimicrob Chemother 58: 85-94.
16. Moubareck C, Gavini F, Vaugien L, Butel MJ, Doucet-Populaire F, (2005) Antimicrobial susceptibility of bifidobacteria. J Antimicrob Chemother 55: 38-44.
17. de la Cochetiere MF, Durand T, Lepage P, Bourreille A, Galmiche JP, et al. (2005) Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 43: 5588-5592.
18. Donskey CJ, Hujer AM, Das SM, Pultz NJ, Bonomo RA, et al. (2003) Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J Microbiol Methods 54: 249-256.
19. Mangin I, Bouhnik Y, Bisetti N, Decaris B, (1999) Molecular monitoring of human intestinal Bifidobacterium strain diversity. Res Microbiol 150: 343-350.
20. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, et al. (2009) Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77: 2367-2375.
21. Dethlefsen L, Huse S, Sogin ML, Relman DA, (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6: e280.
22. Jakobsson HE, Jernberg C, Andersson AF, Sjolund-Karlsson M, Jansson JK, et al. (2010) Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 5: e9836.
23. Magne F, Hachelaf W, Suau A, Boudraa G, Mangin I, et al. (2006) A longitudinal study of infant faecal microbiota during weaning. FEMS Microbiol Ecol 58: 563-571.
24. Mangin I, Suau A, Magne F, Garrido D, Gotteland M, et al. (2006) Characterization of human intestinal bifidobacteria using competitive PCR and PCR-TTGE. FEMS Microbiol Ecol 55: 28-37.
25. Satokari RM, Vaughan EE, Akkermans AD, Saarela M, De Vos WM, (2001) Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67: 504-513.
26. Godon JJ, Zumstein E, Dabert P, Habouzit F, Moletta R, (1997) Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl Environ Microbiol 63: 2802-2813.
27. Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, et al. (1995) Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 61: 3069-3075.
28. Magne F, Abely M, Boyer F, Morville P, Pochart P, et al. (2006) Low species diversity and high interindividual variability in faeces of preterm infants as revealed by sequences of 16S rRNA genes and PCR-temporal temperature gradient gel electrophoresis profiles. FEMS Microbiol Ecol 57: 128-138.
29. Mangin I, Suau A, Gotteland M, Brunser O, Pochart P, (2010) Amoxicillin treatment modifies the composition of Bifidobacterium species in infant intestinal microbiota. Anaerobe 16: 433-438.
30. Sneath PH, Sokal LRR, (1962) Numerical taxonomy. Nature 193: 855-860.
31. Bertrand X, Dufour V, Millon L, Beuvier E, Gbaguidi-Haore H, et al. (2007) Effect of cheese consumption on emergence of antimicrobial resistance in the intestinal microflora induced by a short course of amoxicillin-clavulanic acid. J Appl Microbiol 102: 1052-1059.
32. Barc MC, Bourlioux F, Rigottier-Gois L, Charrin-Sarnel C, Janoir C, et al. (2004) Effect of amoxicillin-clavulanic acid on human fecal flora in a gnotobiotic mouse model assessed with fluorescence hybridization using group-specific 16S rRNA probes in combination with flow cytometry. Antimicrob Agents Chemother 48: 1365-1368.
33. Lode H, von der HN, Ziege S, Borner K, Nord CE, (2001) Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora. Scand J Infect Dis 33: 899-903.
34. Young VB, Schmidt TM, (2004) Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 42: 1203-1206.
35. Gronvold AM, L'abee-Lund TM, Sorum H, Skancke E, Yannarell AC, et al. (2010) Changes in fecal microbiota of healthy dogs administered amoxicillin. FEMS Microbiol Ecol 71: 313-326.
36. Vanhoutte T, Huys G, Brandt E, Swings J, (2004) Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol 48: 437-446.
37. Jernberg C, Lofmark S, Edlund C, Jansson JK, (2007) Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1: 56-66.
38. Dethlefsen L, Relman DA, (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108 Suppl 1: 4554-4561.
39. Matsuki T, Watanabe K, Fujimoto J, Kado Y, Takada T, et al. (2004) Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 70: 167-173.
40. Chachaty E, Bourneix C, Renard S, Bonnay M, Andremont A, (1993) Shedding of Clostridium difficile, fecal beta-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime. Antimicrob Agents Chemother 37: 1432-1435.
41. Leonard F, Andremont A, Leclerq B, Labia R, Tancrede C, (1989) Use of beta-lactamase-producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization. J Infect Dis 160: 274-280.
42. Moore WE, Holdeman LV, (1974) Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol 27: 961-979.
43. Wlodarska M, Finlay BB, (2009) Host immune response to antibiotic perturbation of the microbiota. Mucosal Immunol 3: 100-103.
44. He F, Morita H, Ouwehand AC, Hosoda M, Hiramatsu M, et al. (2002) Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol Immunol 46: 781-785.
45. Menard O, Butel MJ, Gaboriau-Routhiau V, Waligora-Dupriet AJ, (2008) Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Appl Environ Microbiol 74: 660-666.
46. Young SL, Simon MA, Baird MA, Tannock GW, Bibiloni R, et al. (2004) Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol 11: 686-690.
47. Yoshimura K, Matsui T, Itoh K, (2010) Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains. Antonie Van Leeuwenhoek 97: 107-117.